Published • loading... • Updated
A drugmaker is gaining from the side effects of weight-loss drugs
Summary by BizToc
This story is only covered by news sources that have yet to be evaluated by the independent media monitoring agencies we use to assess the quality and reliability of news outlets on our platform. Learn more here.2 Articles
2 Articles
BizTocReposted by 
williamsnews.com
williamsnews.comA drugmaker is gaining from the side effects of weight-loss drugs
When GLP-1 weight-loss drugs from Novo Nordisk (NVO) and Eli Lilly (LLY) first became popular, investors feared it would affect consumer health and food companies. Many thought that if millions of people eat less, companies that sell snacks and supplements would lose customers. Nestlé responded by…
Coverage Details
Total News Sources2
Leaning Left0Leaning Right0Center0Last UpdatedBias DistributionNo sources with tracked biases.
Bias Distribution
- There is no tracked Bias information for the sources covering this story.
Factuality
To view factuality data please Upgrade to Premium
